Eomes Impedes Durable Response to Tumor Immunotherapy by Inhibiting Stemness, Tissue Residency, and Promoting the Dysfunctional State of Intratumoral CD8(+) T Cells.
Sun R, Wu Y, Zhou H, Wu Y, Yang Z, Gu Y, Jiang J, Lu B, Zhu Y. Front Cell Dev Biol. 2021; 9:640224. Epub 2021 Jan 21.